Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer
- PMID: 40465984
- PMCID: PMC12131889
- DOI: 10.1590/1806-9282.20240411
Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer
Abstract
Objective: The aim of this study was to compare the prognostic value of inflammatory indices, including the prognostic nutritional index, advanced lung cancer inflammation index, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, Glasgow Prognostic Score, and C-reactive protein/albumin ratio, in patients with metastatic non-small cell lung cancer and to determine whether any of the indices are correlated.
Methods: The demographic, clinicopathological, and laboratory data of 179 patients with metastatic non-small cell lung cancer who presented to our medical oncology clinic between 2014 and 2021 were retrospectively obtained from the hospital database system.
Results: Among the inflammatory indices, C-reactive protein/albumin ratio (p=0.002), advanced lung cancer inflammation index (p=0.04), and neutrophil/lymphocyte ratio (p=0.008) were associated with overall survival. Multivariate overall survival analysis showed that Eastern Cooperative Oncology Group Performance Status score (HR 1.37; 95%CI 1.06-1.77; p=0.016) and C-reactive protein/albumin ratio (HR 1.13; 95%CI 1.03-1.24; p=0.01) were independent prognostic factors associated with overall survival. Patients with a high and low C-reactive protein/albumin ratio differed statistically significantly in terms of gender, histopathological subtype, history of smoking, and metastatic site (p<0.05). Correlation analysis showed that C-reactive protein/albumin ratio was negatively correlated with advanced lung cancer inflammation index (r=-0.433, p<0.001) and positively correlated with the other four indices (neutrophil/lymphocyte ratio: r=0.368, p<0.001; platelet/lymphocyte ratio: r=0.321, p<0.001; Glasgow Prognostic Score: r=0.537, p<0.001; and prognostic nutritional index: r=0.223, p=0.003).
Conclusion: Our findings show that among the investigated inflammatory indices, C-reactive protein/albumin ratio has the highest prognostic value in patients with metastatic non-small cell lung cancer.
Conflict of interest statement
Similar articles
-
Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Prognostic Nutritional Index as Prognostic Markers for Lung Carcinoma.Br J Hosp Med (Lond). 2024 Oct 30;85(10):1-13. doi: 10.12968/hmed.2024.0270. Epub 2024 Oct 23. Br J Hosp Med (Lond). 2024. PMID: 39475029
-
Correlation of inflammatory indices with staging of esophageal carcinoma: A prospective study at Dr. Ruth K. M. Pfau Civil Hospital, Karachi.J Pak Med Assoc. 2024 Oct;74(10):1784-1790. doi: 10.47391/JPMA.10193. J Pak Med Assoc. 2024. PMID: 39407371
-
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.Lung Cancer. 2017 Sep;111:176-181. doi: 10.1016/j.lungcan.2017.07.024. Epub 2017 Jul 24. Lung Cancer. 2017. PMID: 28838390
-
Role of systemic inflammatory response markers in urological malignancy.Int J Urol. 2019 Jan;26(1):31-47. doi: 10.1111/iju.13801. Epub 2018 Sep 25. Int J Urol. 2019. PMID: 30253448 Review.
-
Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis.Clinics (Sao Paulo). 2015 Jul;70(7):524-30. doi: 10.6061/clinics/2015(07)10. Epub 2015 Jul 1. Clinics (Sao Paulo). 2015. PMID: 26222823 Free PMC article. Review.
References
-
- Mazzella A, Maiolino E, Maisonneuve P, Loi M, Alifano M. Systemic inflammation and lung cancer: is it a real paradigm? Prognostic value of inflammatory indexes in patients with resected non-small-cell lung cancer. Cancers (Basel) 2023;15(6):1854–1854. doi: 10.3390/cancers15061854. - DOI - PMC - PubMed
-
- Wang J, Liu Y, Mi X, Shao M, Liu L. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Ann Palliat Med. 2020;9(3):967–978. doi: 10.21037/apm.2020.04.31. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials